Literature DB >> 29392614

Treatment modalities and outcomes of pleomorphic hyalinizing angiectatic tumor: a systematic review of the literature.

A J Rush1, P D Patel1, S Shemesh1, T K Subhawong2, J Pretell-Mazzini3.   

Abstract

A systematic review of the cases documented in the literature regarding Pleomorphic hyalinizing angiectatic tumor of soft parts (PHAT) was performed in order to identify (1) location on presentation (2) surgical treatment modality (3) recurrence rate (4) any associations between location, age, histology, surgery type on recurrence. A systematic review of medical literature listed on PubMed was conducted identifying any prior case report and/or case series of diagnosed PHAT, with no exclusion based on language or time. Twenty-nine articles were identified removing any articles with duplicated cases yielding a total of 93 cases. Cases were broken down by gender, presenting location (UE/LE/axial), surgery type [wide local resection, non-wide local, wide local with radiation therapy (RT), non-wide local with RT], recurrence, and time to recurrence. The mean age at presentation was 54.5 ± 17.1 (range 10-89) with the 76% of cases appearing in the lower extremity (15% UE, 9% Axial). Of the 93 patients, 74 had a known surgical procedure, 31% WL, 40% NWL, 8% WL + RT, 1% NWL + RT. Of those treated surgically, 63 pts had documented follow-up and 18 (29%) had recurrence. A strong association was observed between surgery type and recurrence. Local recurrence was more common within the group undergoing NWLE in 52% (16/41) of cases (p = 0.002). Kaplan-Meier analysis showed an estimate mean time for recurrence of 43.87 months [95% confidence interval (CI) 24.52-63.22; and standard error (SE) 7.59] for the entire population. A trend was also seen toward males having a shorter disease-free survival than females (29.4 mos. vs. 69.5 mos.). No significant association seen between size, location, histology type and recurrence. PHAT has a characteristic presentation in the LE with a relatively high rate of local recurrence and slow-growing potential. Wide local excision appears to be superior in decreasing recurrence rates and a long-term follow-up period is needed.

Entities:  

Keywords:  NWLE; PHAT; Recurrence; WLE

Mesh:

Year:  2018        PMID: 29392614     DOI: 10.1007/s12306-018-0532-1

Source DB:  PubMed          Journal:  Musculoskelet Surg        ISSN: 2035-5114


  33 in total

1.  Pleomorphic hyalinizing angiectatic tumor: imaging findings.

Authors:  Ty K Subhawong; Andrea P Subhawong; Elizabeth A Montgomery; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2012-06-03       Impact factor: 2.199

Review 2.  Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature.

Authors:  Yi-Che Changchien; Pál Bocskai; Ilona Kovács; Zoltán Hargitai; Sándor Kollár; Miklós Török
Journal:  Pathol Res Pract       Date:  2014-05-04       Impact factor: 3.250

3.  Large pleomorphic hyalinizing angiectatic tumor of the forearm: A multidisciplinary perspective.

Authors:  Philip S Brazio; Alan L Morrison; Mitch Oh; Nelson Goldberg; Cherif N Boutros
Journal:  Surgery       Date:  2015-06-04       Impact factor: 3.982

4.  [Pleomorphic hyalinizing angiectasic soft-tissue tumor. Description of a case].

Authors:  C Gallo; B Murer; F Roncaroli
Journal:  Pathologica       Date:  1997-10

5.  Pleomorphic hyalinizing angiectatic tumor of soft parts: immunohistochemical case study shows cellular composition by CD34+ fibroblasts and factor XIIIa+ dendrophages.

Authors:  J S Silverman; M M Dana
Journal:  J Cutan Pathol       Date:  1997-07       Impact factor: 1.587

6.  Pleomorphic hyalinizing angiectatic tumor: a report of 3 new cases, 1 with sarcomatous myxofibrosarcoma component and another with unreported soft tissue palpebral location.

Authors:  Carmen Illueca; Isidro Machado; Julia Cruz; Sergio Almenar; Rosa Noguera; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-01

7.  Pleomorphic hyalinizing angiectatic tumor: analysis of 41 cases supporting evolution from a distinctive precursor lesion.

Authors:  Andrew L Folpe; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

8.  Spontaneous bruising overlying a subcutaneous swelling: pleomorphic hyalinizing angiectatic tumor, a relatively new entity of intermediate malignancy.

Authors:  Sarah J Felton; Denise Ramlogan
Journal:  Int J Dermatol       Date:  2014-04-16       Impact factor: 2.736

Review 9.  Pleomorphic hyalinizing angiectatic tumour of soft parts: a case report and review of the literature.

Authors:  J R Jaggon; R D C Aitken
Journal:  West Indian Med J       Date:  2007-12       Impact factor: 0.171

10.  TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.

Authors:  Jodi M Carter; William R Sukov; Elizabeth Montgomery; John R Goldblum; Steven D Billings; Karen J Fritchie; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

View more
  2 in total

Review 1.  Pleomorphic Hyalinizing Angiectatic Tumor (PHAT): Review of the Literature with Case Presentation.

Authors:  Gerardo Cazzato; Anna Colagrande; Antonietta Cimmino; Teresa Lettini; Maria Teresa Savino; Carmen Martella; Giuseppe Ingravallo; Leonardo Resta
Journal:  Dermatopathology (Basel)       Date:  2021-04-04

Review 2.  Pleomorphic hyalinizing angiectatic tumor of the vulva: literature review based on a rare presentation.

Authors:  Eveline Cristina da Silva; Rodrigo Fonseca Abreu; Antônio Geraldo Nascimento; Louise De Brot Andrade
Journal:  Autops Case Rep       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.